AdClinical Study For A 2L Treatment Option For Certain Patients With HR+ HER2- mBC. A Treatment May Be An Option For Patients With Metastatic BreastCancer. Learn More.
Service catalog: Treatment Option, Metastatic Breast Cancer, Official HCP Site
AdHow do ADCs deliver cytotoxic agents to metastatic breastcancer cells? How do antibody-drug conjugates address the unmet need in metastatic breastcancer?